Source: Annual Congress 2010 - Novel markers of lung injury
Disease area: Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
C. Bassford, D. Park, D. Webster, G. Perkins, D. Thickett (Birmingham, Coventry, United Kingdom). High mobility group box protein-1 suppresses efferocytosis in ARDS. Eur Respir J 2010; 36: Suppl. 54, 1792

Member's Comments

No comment yet.

Related content which might interest you: Increased shedding of low density lipoprotein receptor-related protein-1 (LRP-1) in patients with acute respiratory distress syndrome (ARDS) prevents cellular clearance of matrix metalloproteinase-2 (MMP-2) and correlates with disease severity Source: Annual Congress 2009 - Acute lung injury: biological mechanisms Year: 2009 Increased expression of sphingosine-1-phosphate and S1PR2 are associated with attenuated macrophage phagocytosis in COPD Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Egr-1 regulates muc5ac expression through activator protein-1 (AP-1) in chronic airway inflammation diseases Source: International Congress 2015 – Translational studies in airway cell biology Year: 2015 High mobility group box protein 1 (HMGB1) production in highly vascularized alveolar lesions causes acute exacerbation in idiopathic pulmonary fibrosis Source: Annual Congress 2005 - Progresses in lung fibrosis Year: 2005 Role of monocyte chemotactic protein-3 and -4 in children with virus exacerbation of asthma Source: Eur Respir J 2008; 32: 1243-1942 Year: 2008 Inhibition of granulocyte activation by surfactant in a 2-yr-old female with meningococcus-induced ARDS Source: Eur Respir J 2002; 19: 776-779 Year: 2002 Roflumilast potently inhibits CXCL1 mediated neutrophil migration in COPD patients Source: Annual Congress 2011 - COPD: clinical studies and animal cell models Year: 2011 Monocyte chemotactic protein-1 in the migration of differentiated leukaemic cells toward alveolar epithelial cells Source: Eur Respir J 2008; 31: 957-962 Year: 2008 LSC - 2018 - Differential effect of ARDS on alveolar macrophage efferocytosis compared to bacterial phagocytosis Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury Year: 2018 Erythromycin attenuates an experimental model of chronic bronchiolitis via augmenting monocyte chemoattractant protein-1 Source: Eur Respir J 2001; 17: 360-367 Year: 2001 Selective decoy-mediated inhibition of activator protein-1 activity in the airways prevents experimental asthmatic inflammation Source: Annual Congress 2005 - Regulation of the allergic and asthmatic response Year: 2005 Altered scavenger receptor expression and response to oxidative stress is linked to defective bacterial phagocytosis in COPD macrophages Source: International Congress 2016 – Mechanisms of disease Year: 2016 Eotaxin and monocyte chemoattractant protein-1 in chronic eosinophilic pneumonia Source: Eur Respir J 2001; 17: 962-968 Year: 2001 Impaired efferocytosis and neutrophil extracellular trap clearance by macrophages in ARDS Source: Eur Respir J, 52 (2) 1702590; 10.1183/13993003.02590-2017 Year: 2018 Impaired monocyte chemotaxis in COPD Source: International Congress 2015 – Mucosal immunology: what’s new in 2015 Year: 2015 Surfactant protein A (SP-A) and alveolar complement activation in patients at-risk for ARDS Source: Eur Respir J 2002; 20: Suppl. 38, 375s Year: 2002 Mesenchymal stromal cells (MSC) anti-microbial effect in acute respiratory distress syndrome (ARDS) is mediated in part by enhanced alveolar macrophage phagocytosis through cell contact-dependent mitochondrial transfer leading to improved macrophage bioenergetics Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair Year: 2016 Regulation, cell-specific expression and metabolism of factor VII activating protease (FSAP) in lungs from patients with acute respiratory distress syndrome (ARDS) and idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2006; 28: Suppl. 50, 823s Year: 2006 Increased susceptibility of M2 monocyte-derived macrophages from COPD patients to oxidative stress Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013 Elevated CCL2 responses in COPD and attenuation by selective chemokine receptor antagonists Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease Year: 2015